Abdalla, H. M. 1997. Chemotherapy of malaria. Review article. J. Egypt. Soc. Parasitol, 27(1), 253-72.
Adebayo, R. A., Sofowora, G. G., Onayemi, O., Udoh, S. J. and Ajayi, A. A.1997. Chloroquine- induced pruritus in fever: contribution of malaria parasitaemia and its effects of prednisolone, niacin and their combination, given with anthistamine. Br. J. Clin. Pharmacol.
Ajayi, A. A., Sofowora, G. G. and Olotu, T. C.1998. Knowledge, attitude and practice of prednisolone prevention of chloroquine induced pruritus among Nigerian health workers. Tropical Doctor, 28 (4), 210-211.
Basco, L. K., and Ringwald, P. 1998. Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am. J. Trop.Med. Hyg., 58(3), 374-7.
Basco, L. K. and Ringwald, P.1998. Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene on Plasmodium falciparum. Am. J. Trop.Med.Hyg., 59 (4), 577-581.
Basilico, N., Pagani, E., Monti, D., Olliaro, P. and Taramelli, D.1998. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J. Antimicrob. Chemo., 42 (1), 55-60.
Batty, K. T., Thu, L. T. A., Davis, T. M. E., Iiet, F. K., Mai, T. X., Hung, N. C., Tien, N. P., Powell. S. M., Thien, H. V., Binh, T. Q., Kim, N. V. A. 1998. pharmarcokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br. J. Clin. Pharmacol., 45, 123- 129.
Batty, K. T., Edwards, G., Davis, T. M. E., Iiet, F. K., Maggs, L. J., Powell. S. M., Kevin, P. 1998. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Eur. J. Pharmacol., 125, 159 - 167.
Beier, J. C. 1993. Malaria sporozoites: survival , Transmission and Disease control. Parasitol. Today, 9(6), 210 - 215.
Black, R. H., Canfield, C. J., Clyde, D. F. and Wernsdorfer, W. H. 1981. Chemotherapy of malaria. 2nd Edition. WHO. Geneva.
Bradley, D. J. and Warhurst, D. C. 1997. Guidelines for the prevention of malaria in travellers from the United Kingdom. Communicable Dis. Rev., 7 (10).
Brown, V., Issak, M. A., Rossi, M., Barboza, P. and Paugam, A. 1998. Epidemic of malaria in north-eastern Kenya. Lancet. North American Edition., 352 (9137), 1356-1357.
Buckling, A. G., Taylor, L. H., Carlton, J. M., Read, A. F. 1997. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proc. R. Soc. Lond. B. Biol. Sci., 264(1381), 553-9.
Carlton, J., MacKinnon, M. and Walliker, D.1998. A chloroquine resistance locus in the rodent malaria parasite Plasmodium. Molecular-and-Biochemical-Parasitology., 93 (1), 57-72.
Chevalier, A. 1996. The encyclopaedia of medicinal plants. BCS. Dorlings Kindlesley. London.
Chung, S. Y., Das, R and Oon, C. T. 9198. Treatment of severe falciparum malaria with artesunate and mefloquine. Singapore. Med. J., 39(5), 208-10.
Cox, F. E. G. 1992. Malaria parasites: Getting into the liver. Nature, 359, 361 - 362.
Davis, T. M. E. 1997. Antimalarial drugs and glucose metabolism. Br. J. Clin. Pharmacol. 44, 1-7.
Doherty, T. and Pinder, M. 1997. Malaria prevention: Where do we go from here? Current opinion in infectious Diseases. 10, 466-468.
Duraisingh, M. T., Curtis, J. and Warhurst, D. C. 1998. Plasmodium falciparum: Detection of polymorphisms in the Dihydrofolate reductase and Dihydropteroate synthetase genes by PCR and restriction digestion. Experimental Parasitology., 89 (1),1-8.
Fleck, S. L., Robinson, B. L., Peters, W., Thevin, F., Boulard, Y., Glenat, C., Caillard, V., Landau, I. 1997. The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. Ann. Trop. Med.Parasitol., 91(1), 25-32.
Fryauff, D. J., Cryz, S. J., Widjaja, H., Mouzin, E., Church, L. W. P., Sutamihardja, M. A., Richards, A. L., Subianto, Budi., Hoffman, S. L. 1998. Humoral immune response to tetanus-diphtheria vaccine given during extended use of chloroquine or primaquine malaria chemoprophylaxis. Journal of Infectious Diseases., 177 (6), 1762-1765.
Fryauff, D. J., Widjaja, H., Mouzin, E., Church, L. W. P., Sutamihardja, M. A., Subianto, B., Hoffman, S. L. Ratiwayanto, S., Hadiputranto, H., Corradin,G. 1999. Lymphocyte response to tetanus toxin T-cell epitopes: Effects of tetanus vaccination and concurrent malaria prophylaxis. Vaccine, 17 (1), 59-63.
Fryauff, D. J., Prodjodipuro, P., Basri, H., Jones, T. R., Mouzin, E., Widjaja, H., Subianto, B. 1998. Intestinal parasite infections after extended use of chloroquine or primaquine for malaria prevention. Journal of Parasitology, 84 (3), 626-629.
Fu, S and Xiao, S.H. 1991. Pyronaridine: A new antimalarial drugs. Parasitol. Today, 7(11), 310 - 313.
Ginsburg, H., Famin, O., Zhang, J.and Krugliak, M. 1998. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochemical Pharmacology, 56 (10), 1305-1313.
Gilles, H. M. and Warrell, D. A. 1990. Bruce-Chwatt's Essential Malariology. Third Edition. Edward Arnold. London.
Hatz, C., Abdulla, S., Mull, R., Schellenberg, D., Gathmann, I., Kibatala, P., Beck, H. P., Tanner, M., Royce, C. 1998. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Tropical Medicine and International Health, 3 (6), 498-504.
Hellgren, U., Berggreb-Palme, I., Bergqvist, Y. and Jerling, M. 1997. Enantioselective pharmacokinetics of mefloquine during long-term intake of the prophylactic dose. Br. J. Clin.Pharmacol., 44, 119 -124.
Heppner, D. G. and Ballou, W. R. 1998. Malaria in 1998: Advances inm diagnosis, drugs and vaccine development. Trop. And Travel Assoc. Dis., 519 - 518.
Hien, T. T. and White, N. J. Qinghasu. 1993. The Lancet, 341, 603.
Hoshen, M. B., Stein, W. D. and Ginsburg, H. 1998. Modelling the chloroquine chemotherapy of falciparum malaria: The value of spacing a split dose. Parasitology.
Hoskins, J. M., Shenfield, G. and Gros, A. S. 1998. Relationship between proguanil metabolic ratio and CYP2C19 genotype in a caucasian population. Br. J. Clin. Pharmacol., 46, 499-504.
Hudson, A. T. 1993. Atovaquone, a novel; broad-spectrum anti-infective drug. Parasitol. Today, 9 (2), 66- 68.
Ismail, F. M., Dascombe,M. J., Carr, P., Merette, S. A and Rouault, P. 1998. Novel aryl-bis-quinolines with antimalarial activity in-vivo. J. Pharm. Pharmacol., 50(5), 483-92.
Karbwang, J., Na-Bangchang, K., Thanavibul, A., Bunag, D., Siddhi, T.
C. and Harinasuta, T. 1992. Comparison of oral artemether and mefloquine
in acute uncomplicated falciparum malaria. The Lancet, 340, 1245-8.
Karbwang, J., Na-Bangchang, K., Thanavibul, A and Molunto, P.1998. Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol., 92(1), 31-6.
Karbwang, J., Na-Bangchang, K., Tin, T., Sukontason, K., Rimchala, W. and Harinasuta, T. 1998. Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure. Br. J. Clin. Pharmacol., 45, 597 - 600.
Koella, J. C. 1998. Cost and benefits of Resistance against Antimalarial drugs. Parasitol. Today, 14 (9), 360 - 364
Kondrachine, A. V. and Trigg, P. I. 1997. Global overview of malaria-WHO. Ndian. J. Med. Res.
Krogstad, D. J. 1987. Efflux of chloroquine for P. falciparum, mechanism of chloroquine resistance. Science. 238, 1283.
Krogstad, D. J., Schlessinge, P. H. and Gluzman, I. Y. 1992. The specificity of chloroquine. Parasitol Today, 8 (6).
Lobel, H. O., Miani, M., Eng, T., Bernard, K. W., Hightower, A. W., Campbell, C. C. 1993. Long-term malaria prophylaxis with weekly mefloquine. The Lancet, 341,848 - 851.
Lo-Patwari, A. K.1997. Chemotherapy of malaria. Indian. Pediatr., 34(1), 83.
MacSween, R. N. M. and Whaley, K. 1992. Muir’s textbook of pathology. Edward Arnold. London.
Massele, A. Y., Kulewo, C., Aden-Abdi, Y., Tomson, G., Diwan, V. K., Ericsson, O., Rimoy, G., Glustafsson, L. L. 1997. Chloroquine-therapeutic use in malaria. Eur. J. Clin. Pharmacol.
McIntosh, H. M. and Greenwood, B. M. 1998. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria-a systematic review. Annals of Tropical Medicine and Parasitology, 92 (3), 265-270.
Mharakurwa, S., Rangarira, R., Murahwa, F. C. and Chandiwana, S. K. 1998. Status of chloroquine efficacy against falciparum malaria in the Mola area of Kariba district, Zimbabwe. Annals of Tropical Medicine and Parasitology, 92 (6), 655-661.
Molneux, M and Fox, R.1993. Diagnosis and treatment of malaria in Britain. Br. Med. J, 306, 1175 - 1183.
Mordmuller, B., Graninger, W., Kremsner, P. G. 1998. Malaria therapy in the era of chloroquine resistance. Wien. Klin. Wochenschr., 110(9), 321-5.
Na-Bangchang, K., Congpoung,K., Sirichaisinthop, J., Suprakorb, K., Karbwang, J.1997. Compliance with a 2 day course of artemether-mefloquine in an area highly mult-drug resistant P. falciparum malaria. Br. J. Clin. Pharmacol.
Nosten, F., Kuile, F. O., Luxemburger, C., Woodrow, C., Kyle, D. E., Siddhi, C. and White, N. J. 1993. Cardiac effects of Antimalarial treatment with halofantrine. The Lancet, 341, w1054 -1056.
Nwanyanwu, O. C., Ziba, C., Kazembe, P. N., Gamadzi, G., Gondwe, J. and Redd, S. C. 1996. The effect of oral iron therapy during treament for plasmodium falciparum malaria with sulphadoxine-pyrimethamine on Malawian children under 5 years of age. Ann. Trop. Med. Parasitol., 90(6), 589-595.
Oduola, A. M., Sowunmi, A., Milhous, W. K., Brewer, T. G., Kyle, D.E., Gerena, L., Rossan, R. N., Salako, L. A. and Schuster, B. G. 1998. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. Am. J. Trop. Med. Hyg., 58(5), 625-9.
Parkard, R. M. 1997. Malaria dreams: Postural visions of health and development in the third world. Med. Antropol.
Peter, W and Robinson, B. L. 1997. The chemotherapy of rodent malaria. LV. Interactions between pyronaridine and artemisinin. Ann. Trop. Med. Parasitol., 91(2), 141-5.
Rang, H. P., Dale, M. M. and Ritter, J. M. 1996. Pharmacology. Third edition. Churchill Livingstone. England.
Reyburn, H., Behrens, R. H., Warhurst, D and Bradley, D. 1998. The effect of chemoprophylaxis on the timing of onset of falciparum malaria. Tropical Medicine and International Health, 3 (4), 281-285.
Ridley, R. G. and Hudson, A. T. 1998. Chemotherapy of malaria. Current Opinion in infectious Dis., 11, 691 - 705.
Ridley, R. G. 1998. Malaria: Dissecting chloroquine resistance. Current Biology, 8 (10), R346-R349.
Rimchala, P., Karbwang, J., Sukontason, K., Banmairuroi, V., Molunto, P and Na- Bangchang, K.1996. Pharmacokinetics of quinine in patients with chronic renal failure. Eur. J. Clin. Pharmacol., 49, 497-501.
Ringwald, P., Bickii, J and Basco, L. K. 1998. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children. Clin. Infect. Dis., 26(4), 946-53.
Roitt, I., Brostoff, J. and Male, D. 1993. Immunology, 3rd Edition. Mandarin offset (HK), Hong Kong.
Sarma, P. S., Mandal, A. K. and Khamis, H. J. 1998. Allopurinol as an additive to quinine in the treatment of acute complicated falciparum malaria. Am. J. Trop. Med. Hyg., 58(4), 454-7.
Sheng, W. D., Jiddawi, M. S., Hong, X. Q., Abdulla, S. M.1997. Treatmant of Chloroquine - resitant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr. Med. J.
Sidhu, J. S., Ashton, M., Huong, N. V., Hai, T. N., Karlsson, M. O., Sy, N. D., Jonsson, E. N and Cong, L. D. 1998. Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria. Br. J. Clin. Pharmacol., 45(4), 347-54.
Simooya, O. O., Sijumbil, G. Lennard, M. S. and Turker, G. 1998. Halofantrine and chloroquine inhibit CY2D6 activity in healthy Zambians. Br. J. Clin. Pharmacol., 45, 315 - 317.
Solomone, S. and Godfraind, T. 1990. Drugs that reverse chloroquine resistance in malaria. Tips, 11, 475 - 476.
Sowunmi, A. and Oduola, A. M. J. 1998. Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimethamine. Eur. J. Clin. Pharmacol., 54, 221-226.
Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T. and Salako, L. A. 1998. Enhancement of the antimalarial effect of chloroquine by chloropheniramine in vivo. Tropical Medicine and International Health, 3 (3), 177-183.
Steffen, R., Fuchs, E., Sciladknecht, J., Naef, U., Funk, M., Schlagenhauf, P.,Howard, P. P., Nevil, C and Sturchler, D. 1993. Mefloquine compared with other malaria chemoprophylacti regimens in tourists visiting East Africa. The Lancet, 341:1299.
Thompson, P. E. and Werbel, L. M. 1972. Antimalarial Agents: Chemistry and pharmacology. Medicinal Chemistry. 12.
Valecha, N., Gupta, S., Usha, D., Biswas, S., Sharma, A., Adak, T., Asthana, O.P., Sharma, V. P. 1997. Efficacy of alpha,beta-arteether in acute uncomplicated P. falciparum malaria. Int. J. Clin. Pharmacol. Res., 17(1): 11-5.
Trigg, P, I. and Kondrachine, A. V.1997. Malaria control in the 1990s. Bulletin of the World Health Organization, 76 (1), 11-16.
Verhoeff, F. H., Brbin, B. J., Mesache, P., Kachale, B., Kazembe, P. and Van-der-kaay, H. J. P. 1997. falciparum malaria with sulphadoxin-pyrimethamine in Southern Malawi. Ann. Trop. Med. parasitol.
Ward, S, A. 1988. Mechanisms of chloroquine resistance in malarial chemotherapy. Tips, 9, 241 - 246.
Weidekamm, G., Rusing, G., Caplain, H., Sorgel, F. and Crevoisier, C. 1998. Lack of bioequivalence of a generic mefloquine tablet with the standard product. Springer- Verlag.
White-N-J.1994. mefloquine in the prophylaxis and treatment of malaria. Br. Med. J., 308, 286 - 287.
White, N. J. 1998. Why is it that antimalarial drug treatments do not always work? Ann. Trop. Med. Parasitol, 92 (4) 449-458.
WHO. 1990. Practical chemotherapy. Report of a WHO scientific group. Geneva.
Yeo, A. E., Seymour, K. K., Rieckmann, K. H. and Christopherson, R. I. 1997. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Biochem. Pharmacol., 53(7), 943-50.
Zalis, M G., Pang, L., Silveira, M. S., Milhous, W. K. and Wirth, D. F. 1998. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am. J. Trop. Med. Hyg., 58(5), 630-7.
Zucker, J. R., Perkins, B. A., Jafari, H., Otieno, J., Obonyo, C. and
Campbell, C. C. 1997. Clinical signs for the recognition of children with
moderate or severe anaemia in western Kenya. Bull. World. Health. Organ.,
75 (1), 97-102.
INTERNET REFERENCES
http://homepages.uel.ac.uk/D.P.Humber/parasite/malaria/.html: Power point presentation on malaria. Visited 20/1/99, 1/3/99, 7/5/99
http://www.rph.wa.gov.au/labs/haem/malariah.html: Advice on malaria for travellers. Visited 4/10/98, 11/12/98, 1/3/99, 7/5/99
http://jupiter.aho.ch/yellow/tablets.html: Current malarial prophylaxis Visited; 19/1/99, 7/5/99.
http://www.malaria.org/new.html: malaria foundation interaction. Visited; 11/12/98, 7/5/99.
http://www.who.int/ctd/html/malaria.html: Malaria Prevention and Control. Visited; 19/3/99, 7/5/99.
http://www.wellcome.ac.uk/mim/: Multilateral Initiative on Malaria. Visited; 19/3/99, 7/5/99.
http://www.sanger.ac.uk/projects/p-falciparum: P. falciparum Blast server. Visited 19/3/99, 7/5/99.
http://www.tigr.org/tdb/edb/pfdb/pfdb.html: The Plasmodium falciparum Genome Database (PFDB). Visited 19/3/99, 7/5/99.
http://sequence-www.stanford.edu/group/malaria/index.html: Plasmodium falciparum (Pf). Genome Project Sequencing at the Stanford DNA Sequence and Technology Center Chromosome 12. Visited; 19/3/99, 7/5/99.
http://www.ncbi.nlm.nih.gov/Malaria/: Malaria Genetics & Genomics. Visited; 19/399, 7/5/99.
http://www.niaid.nih.gov/slideshow/: malaria research information. Visited; 19/3/99, 7/5/99.
http://www.wehi.edu.au/research/infimm/malaria1.html: Malaria Program. Visited; 19/3/99, 7/5/99.
http://www.nature.com./: Electronic journal. Visited; 18/2/99, 7/5/99.
http://www.cdc.gov/travel/malinfo.htm: Malaria: General Information. Visited;
22/3/99, 7/5/99.
http://actmalaria.org/ : Asian collaborative training
network for malaria.Visited; 7/5/99.
Home
pageMalariaCurrent
AntimalarialsQinghaosuConclusion